Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.13p
   
  • Change Today:
      0.15p
  • 52 Week High: 5.90p
  • 52 Week Low: 1.09p
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 1,364,271
  • Market Cap: £15.62m
  • RiskGrade: 328
  • Beta: 0.05

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £46,514
Lisa Baderoon 583,963 £18,249
Tim Franklin 525,000 £16,406

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 80,590,404 £2,518,450
Luca & Associates AG 22,000,000 £687,500
Invesco Ltd 17,872,341 £558,511
Aviva Investors Global 11,285,180 £352,662
Alora Pharmaceuticals LLC 10,909,091 £340,909
M&G Investments 7,600,000 £237,500
Prudential plc 7,600,000 £237,500
Capital Income Builder 4,870,367 £152,199
Dr R Zimmer 4,551,553 £142,236
Odey Asset Management 3,433,319 £107,291
Rhone Trustees (Switzerland) SA 3,386,000 £105,812
Pictet Overseas Trust Corporation Limited 3,287,500 £102,734

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 3.13p
Change Today 0.15p
% Change 5.04 %
52 Week High 5.90p
52 Week Low 1.09p
Volume 1,364,271
Shares Issued 499.72m
Market Cap £15.62m
Beta 0.05
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.4% below the market average74.4% below the market average74.4% below the market average74.4% below the market average74.4% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Price Trend
85.39% above the market average85.39% above the market average85.39% above the market average85.39% above the market average85.39% above the market average
91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 09-May-2025

Time Volume / Share Price
16:28 1,545 @ 2.90p
16:10 175,000 @ 3.35p
15:49 70,000 @ 3.08p
15:47 470 @ 2.91p
15:36 20,000 @ 3.13p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page